140
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia

, , , , , , , , , , , , , & show all
Pages 1512-1514 | Received 24 Sep 2021, Accepted 14 Jan 2022, Published online: 08 Feb 2022

References

  • Den Boer ML, Van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10(2):125–134.
  • Roberts KG, Gu Z, Payne-Turner D, et al. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol. 2017;35(4):394–401.
  • Stock W, Luger SM, Advani AS, et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood. 2019;133(14):1548–1559.
  • Chiaretti S, Messina M, Della Starza I, et al. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. Haematologica. 2021;106(6):1559–1568.
  • Chiaretti S, Messina M, Grammatico S, et al. Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. Br J Haematol. 2018;181(5):642–652.
  • Chiaretti S, Taherinasab A, Canichella M, et al. The validation of the BCR/ABL1-like predictor across laboratories shows reproducibility of results. Blood. 2019;134(1):5211–5211.
  • Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol. 1981;47(4):553–561.
  • Harvey RC, Tasian SK. Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia. Blood Adv. 2020;4(1):218–228.
  • Foà R, Bassan R, Vitale A, et al. Dasatinib-blinatumomab for Ph-positive acute lymphoblastic leukemia in adults. N Engl J Med. 2020;383(17):1613–1623.
  • Li W, Cooley LD, August KJ, et al. Cuplike nuclear morphology is highly associated with IKZF1 deletion in pediatric precursor B-cell ALL. Blood. 2019;134(3):324–329.
  • Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005–1015.
  • Fazio F, Barberi W, Cazzaniga G, et al. Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript. Leuk Lymphoma. 2020;61(2):469–472.
  • Lunghi M, Patriarca A, Greco M, et al. Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia. Leuk Lymphoma. 2021;62(3):755–757.
  • Cerezo L, Shuster JJ, Pullen DJ, et al. Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A pediatric oncology group study. Am J Clin Pathol. 1991;95(4):526–531.
  • Jia S, Jae J, Hsia CC. Case report of granular acute lymphoblastic leukemia and review of the literature. Clin Case Rep. 2018;7(1):123–127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.